Login to Your Account



Will Hutchison Medipharma deliver the next discovered-in-China world-class drug?

By Shannon Ellis
Staff Writer

Wednesday, March 11, 2015

Hutchison Medipharma Ltd. (HMP) has gone from running a marathon to a sprint. HMP's pipeline has quickly grown from seven clinical trials to 16, 13 of which are phase Ib/II studies.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription